Arcutis Biotherapeutics, Inc.
ARQT
Classificação em ações
#4041
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Preço da ação
$31.91
Última sincronização: 2026-10-21
Valor de mercado
$4.01B
Variação (1 dia)
-2.77%
Variação (1 ano)
61.08%
País
US
Negociar Arcutis Biotherapeutics, Inc. (ARQT)
Categoria
Healthcare
Histórico de preços das ações de Arcutis Biotherapeutics, Inc. (ARQT)
Preço de fecho mais alto: $27.20 em 2026-10-01
Preço de fecho mais baixo: $21.80 em 2020-01-01
Preço de fecho mais baixo: $21.80 em 2020-01-01
Histórico de preços das ações da Arcutis Biotherapeutics, Inc. de 2020 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | -13.06% |
| 2025 | 117.39% |
| 2024 | 438.98% |
| 2023 | -84.13% |
| 2022 | -9.27% |
| 2021 | -38.74% |
| 2020 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.89 | -3.74% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
